Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mats Lambe

Showing results (141-150 of 239) with videos related to

Pageof 24
Sort By:
American Journal of Epidemiology|October 12, 2017
Adjusting Expected Mortality Rates Using Information From a Control Population: An Example Using Socioeconomic StatusHannah Bower, Therese M-L Andersson, Michael J Crowther, et al.
International Journal of Cancer|December 15, 2015
Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort studyFrederik B Thomsen, Yasin Folkvaljon, Hans Garmo, et al.
Journal of the American Academy of Dermatology|December 3, 2014
Mortality in women with pregnancy-associated malignant melanomaAnna L V Johansson, Therese M-L Andersson, Anna Plym, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2011
Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancerAnders Berglund, Hans Garmo, David Robinson, et al.
Scandinavian Journal of Urology|February 2, 2018
Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in SwedenIngela Franck Lissbrant, Eugenio Ventimiglia, David Robinson, et al.
Scandinavian Journal of Urology|July 11, 2015
Dashboard report on performance on select quality indicators to cancer care providersPär Stattin, Fredrik Sandin, Torsten Sandbäck, et al.
Scandinavian Journal of Urology and Nephrology|November 20, 2009
PCBaSe Sweden: a register-based resource for prostate cancer researchEva Hagel, Hans Garmo, Anna Bill-Axelson, et al.
Haematologica|September 25, 2025
Loss of life expectancy in patients with myeloproliferative neoplasms in SwedenYuliya Leontyeva, Anna Ravn Landtblom, Malin Hultcrantz, et al.
The Journal of Urology|February 11, 2014
Rehospitalization after radical prostatectomy in a nationwide, population based studyJón Öm Friðriksson, Erik Holmberg, Jan Adolfsson, et al.
BMC Cancer|April 6, 2017
Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohortJennifer C Melvin, Hans Garmo, Lars Holmberg, et al.
Pageof 24

Showing results (141-150 of 239) with videos related to

Sort By:
Pageof 24
American Journal of Epidemiology|October 12, 2017
Adjusting Expected Mortality Rates Using Information From a Control Population: An Example Using Socioeconomic StatusHannah Bower, Therese M-L Andersson, Michael J Crowther, et al.
International Journal of Cancer|December 15, 2015
Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort studyFrederik B Thomsen, Yasin Folkvaljon, Hans Garmo, et al.
Journal of the American Academy of Dermatology|December 3, 2014
Mortality in women with pregnancy-associated malignant melanomaAnna L V Johansson, Therese M-L Andersson, Anna Plym, et al.
European Journal of Cancer (Oxford, England : 1990)|August 20, 2011
Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancerAnders Berglund, Hans Garmo, David Robinson, et al.
Scandinavian Journal of Urology|February 2, 2018
Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in SwedenIngela Franck Lissbrant, Eugenio Ventimiglia, David Robinson, et al.
Scandinavian Journal of Urology|July 11, 2015
Dashboard report on performance on select quality indicators to cancer care providersPär Stattin, Fredrik Sandin, Torsten Sandbäck, et al.
Scandinavian Journal of Urology and Nephrology|November 20, 2009
PCBaSe Sweden: a register-based resource for prostate cancer researchEva Hagel, Hans Garmo, Anna Bill-Axelson, et al.
Haematologica|September 25, 2025
Loss of life expectancy in patients with myeloproliferative neoplasms in SwedenYuliya Leontyeva, Anna Ravn Landtblom, Malin Hultcrantz, et al.
The Journal of Urology|February 11, 2014
Rehospitalization after radical prostatectomy in a nationwide, population based studyJón Öm Friðriksson, Erik Holmberg, Jan Adolfsson, et al.
BMC Cancer|April 6, 2017
Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohortJennifer C Melvin, Hans Garmo, Lars Holmberg, et al.
Pageof 24